Search results

• Delivering the foundation for Croda's R&D digital program

  Global Research and Development Digital Program across all R&D locations.

• Focusing on D&I in Asia

  Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.

• Analyst consensus

  Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.

• Investing in mRNA and gene therapy

  As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology.

• Our Board activity in 2025

  An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.

• ASD Kaleka Mosaik Initiative Impact Fund

  We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.

• Sustainable ways of working in R&D

  We are focused on aligning the work of our global R&D teams with the United Nations Sustainable Development Goals (SDGs).

• Externally validated avoided emissions

  The emissions savings of this new product were revealed during its sustainability assessment, part of the new way of working for our innovation teams to support our Commitment.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• Media coverage Page Summary Title

  Media coverage Page Summary Description

• Industrial Specialties business review

  Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Sustainability Progress Statement

  Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.

• Climate Positive

  By 2030, we will be Climate Positive.

• Chief Executive sustainability statement

  “By thinking boldly, acting with purpose, and living our values every day, we are bringing Smart science to improve lives™ to life and working hard to achieve our commitment to be the most sustainable supplier of innovative ingredients by 2030, delivering solutions to tackle some of the world’s biggest challenges”

• People Positive

  By 2030, we will be People Positive.

• North America

  Croda Inc is the North American headquarters for Croda, we have four manufacturing sites, four innovation centres and four sales hubs in the region.

• Acquisitions

  Commercialising and increasing our access to new ideas and technologies.

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Consumer Care sustainability review

  Connecting sustainability to people, making it personal, is core to the sustainability focus within the Consumer Care business. Consumers desire personal care products that deliver performance, without negatively impacting the planet. Keeping this at the core creates value for our customers’ brands and the consumers they serve.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.